Roche's Tecentriq notches third cancer cocktail trial win

ZURICH (Reuters) - Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for the Swiss drugmaker as it seeks to muscle in on space dominated by Merck and Bristol-Myers Squibb.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news